| |
1 week before radiation therapy onset |
3 months after radiation completion |
Adjusted group differences in mean
change over 20 weeks |
| CG |
PG |
CG |
PG |
Mean |
95% CI |
P valuea |
| Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
| Urinary symptoms |
16.2 |
6.5 |
18.8 |
5.6 |
24.2 |
15.8 |
38.7 |
16.3 |
-14.1 |
-24.7 |
-3.4 |
0.011 |
| Bowel symptoms |
16.2 |
19.2 |
19.5 |
22.2 |
25.0 |
12.4 |
20.0 |
18.0 |
5.4 |
-4.5 |
15.4 |
0.275 |
| Treatment-related symptoms |
27.2 |
14.9 |
25.0 |
9.4 |
39.2 |
17.2 |
31.1 |
16.6 |
7.9 |
-3.1 |
18.9 |
0.155 |
| Sexual activity |
18.3 |
24.7 |
22.5 |
25.5 |
16.7 |
22.9 |
20.8 |
25.3 |
-3.5 |
-19.0 |
12.0 |
0.652 |
Abbreviations: CG, curcumin group; PG, placebo group; ANCOVA, analysis of covariance; CI, confidence interval
aBetween-group change by ANCOVA adjusted for baseline values |
